Organization
Abbott, Abbott Park, United States
3 abstracts
Abstract
ADALIMUMAB IS EFFECTIVE IN REDUCING SIGNS AND SYMPTOMS IN ANKYLOSING SPONDYLITIS PATIENTS WITH TOTAL SPINAL ANKYLOSIS – RESULTS FROM ATLASOrg: University Hospital Maastricht, Maastricht, Netherlands, Denver Arthritis Clinic, Denver, United States, Ruhr University Bochum, Bochum, Germany, Clinical Research Center of Reading, W. Reading, United States, Hospital Monte Naranco, Oviedo-Asturias, Spain,
Abstract
ACHIEVING LONG-TERM COMPREHENSIVE DISEASE CONTROL WITH ADALIMUMAB AND METHOTREXATE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS IN THE OPTIMA STUDY Org: Univ of Leeds, Leeds, United Kingdom, Medical Univ of Vienna & Hietzing Hospital, Vienna, Austria, U of Texas Southwestern Med Center, Dallas, United States, Karolinska Univ Hospital, Stockholm, Sweden, Abbott, Abbott Park, United States,
Abstract
BIOLOGIC FREE DISEASE CONTROL (BFDC) IN EARLY RA: PREDICTORS OF SUCCESSFUL WITHDRAWAL OF ADALIMUMAB (ADA) AFTER ACHIEVING STABLE LOW DISEASE ACTIVITY WITH ADA PLUS METHOTREXATE (MTX) – DATA FROM THE OPTIMA STUDY Org: Medical Univ of Vienna, Vienna, Austria, Leeds Teaching Hospital, Leeds, United Kingdom, U of Texas Southwestern Med Center, Dallas, United States, Karolinska Univ Hospital, Stockholm, Sweden, Abbott, Abbott Park, United States,